CEOs From OpenAI, Anthropic Warn Congress on AI Bioweapons
Top AI chiefs urged Congress to curb risks as AI tech makes it easier to design dangerous biological materials. The l...
Explore how weekly and monthly automatic buys work for Dividend Aristocrats ETFs and why they can simplify investing. Learn practical steps to set up automatic contributions.
16,919 articlesTop AI chiefs urged Congress to curb risks as AI tech makes it easier to design dangerous biological materials. The l...
As tax time approaches, the choice between short-term bond options can shape your liquidity and after-tax income. Thi...
JPMorgan argues the macro bet that fueled Bitcoin gains is cooling, with BTC near $63,000 as markets digest easing te...
As peace hopes buoy mood, major indices climb and big tech names surge. Discover what drove the stock market today, j...
XRP is hovering around $1.10 with steady buying activity backing a high weekly volume. While the price sits tight, tr...
AVUV has climbed this year, but rate expectations and bank exposure keep its outlook uncertain. Here’s what AVUV inve...
Nvidia’s shares lag the broader chip rally even as demand for AI accelerates, prompting questions about earnings timi...
The strait hormuz back under renewed conflict tests oil bulls and hedges. Markets brace for higher volatility as crud...
A focused infrastructure fund rode the AI build-out to roughly 28% gains through mid-2026, underscoring how concentra...
Investors are watching a policy rethink unfold. This article explains how chair kevin warsh just signals a new inflat...
A notable stake sale in Arcellx turned heads in biotech investing. This article unpack the $26 million exit, why the ...
Nearly $7.8 trillion sits in U.S. money market funds, awaiting a catalyst. As liquidity rotates back into risk assets...